A Safety and Tolerability Study of REGN88(SAR153191) in Subjects With Rheumatoid Arthritis

NCT01026519 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: REGN88
OTHER: Placebo

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]